Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Organovo Holdings Inc
0R02Current price
0.52 USD
0 USD (0.00%)
Last closed
0.57 USD
Company
www.organovo.com
ISIN
US68620A2033
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
8 911 178 USD
Yield for 12 month
-51.17 %
1Y
3Y
5Y
10Y
15Y
0R02
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3 clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus on non-alcoholic steatohepatitis and primary biliary cholangitis. It has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California. Address: 11555 Sorrento Valley Road, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.1 USDP/E ratio
–Dividend Yield
–Current Year
+109 000 USD
Last Year
+370 000 USD
Current Quarter
+39 000 USD
Last Quarter
+29 000 USD
Current Year
-171 000 USD
Last Year
+77 000 USD
Current Quarter
-33 000 USD
Last Quarter
-41 000 USD
Key Figures 0R02
1 year
3 years
5 years
10 years
EBITDA
-13 994 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-73.67 %
PEG Ratio
–
Return On Equity TTM
-151.72 %
Wall Street Target Price
6.1 USD
Revenue TTM
73 000 USD
Book Value
0.46 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-48 %
Dividend Yield
–
Gross Profit TTM
-8 515 000 USD
Earnings per share
-1.38 USD
Diluted Eps TTM
-1.38 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0R02
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0R02
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
19.08.2020
Dividend Date
19.08.2020
Stock Valuation 0R02
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
54.9201
Price Sales TTM
122.0709
Enterprise Value EBITDA
-0.3358
Price Book MRQ
1.3376
Financials 0R02
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0R02
For 52 weeks
0.5 USD
2.05 USD
50 Day MA
0.63 USD
Shares Short Prior Month
115 307
200 Day MA
0.95 USD
Short Ratio
0.98
Shares Short
141 351
Short Percent
0.93 %
BeatStart